The revolutionary and psychiatrist Frantz Fanon was a foundational figure in postcolonial and decolonial thought and practice, yet his psychiatric work still has only been studied peripherally. That is in part because most of his psychiatric writings have remained untranslated. With a focus on Fanon's key psychiatry texts, Frantz Fanon: Psychiatry and Politics considers Fanon's psychiatic writings as materials anticipating as well as accompanying Fanon's better known work, written between 1952 and 1961 (Black Skin, White Masks, A Dying Colonialism, Toward the African Revolution, The Wretched of the Earth). Both clinical and political, they draw on another notion of psychiatry that intersects history, ethnology, philosophy, and psychoanalysis. The authors argue that Fanon's work inaugurates a critical ethnopsychiatry based on a new concept of culture (anchored to historical events, particular situations, and lived experience) and on the relationship between the psychological and the cultural. Thus, Gibson and Beneduce contend that Fanon's psychiatric writings also express Fanon's wish, as he puts it in The Wretched of the Earth, to "develop a new way of thinking, not only for us but for humanity."

It has been almost forty years since Norman G. Bowery discovered and named this "non-GABAA" receptor the GABAB receptor. It has been almost ten years since the last comprehensive book presentation focused on GABAB receptors. The main goal of this book is to provide the field with a contemporary and comprehensive perspective on the GABAB receptor, its physiological relevance, and its therapeutic potential. The volume is organized into introductory and special interest sections presented by experts who study the GABAB receptor from structural, signaling, pharmacologic, physiological, pathophysiological, and therapeutic perspectives. The book aims to appeal to a broad spectrum of biomedical and clinical scientists - any scholars with an interest in GABAB receptor. The editors hope readers find this work to be thought-provoking, instructive, and informative.

This new, and heavily revised, edition of Psychopharmacology, provides a comprehensive scientific study of the effects of drugs on the mind and behaviour. With the growing prevalence of psychiatric and behavioral disorders and the rapid advances in the development of new drug therapies, this textbook offers an essential understanding of the necessary details of drug action. The book presents its coverage in the context of the behavioral disorders they are designed to treat, rather than by traditional drug classifications, to strengthen understanding of the underlying physiology and neurochemistry, as well as the approaches to treatment. Each disorder from the major diagnostic categories is discussed from a historical context along with diagnostic criteria and descriptions of typical cases. In addition, what we presently know about the underlying pathology of each disorder is carefully described. Providing a solid foundation in psychology, neuroanatomy and physiology, the book also offers a critical examination of drug claims, as well as coverage of evidence-based alternatives to traditional drug therapies. Throughout, this text discusses how drug effectiveness is measured in both human and animal studies. Topics new to this edition include: a stronger emphasis on the environmental impacts on drug effectiveness; more on the mechanisms of adverse reactions to drugs and information on managing drug side effects; the risks and benefits of using "mood stabilizing drugs" to address behavior in youth with ADHD or ASD; and discussion of the research-to-practice gap in pharmacological care for children and adolescents. Accompanied by a robust companion website of instructor materials, this textbook is ideal for undergraduate and pre-professional students on courses in Psychopharmacology, Clinical Psychopharmacology, Drugs and Behavior. It is a valuable contribution to highlight the symbiotic relationship between psychopharmacology and the neural and behavioral sciences.

This comprehensive book thoroughly addresses all aspects of health care transition of adolescents and young adults with chronic illness or disability; and includes the framework, tools and case-based examples needed to develop and evaluate a Health Care Transition (HCT) planning program that can be implemented regardless of a patient's disease or disability. Health Care Transition: Building a Program for Adolescents and Young Adults with Chronic Illness and Disability is a uniquely inclusive resource, incorporating youth/young adult, caregiver, and pediatric and adult provider voices and perspectives. Part I of the book opens by defining Health Care Transition, describing the urgent need for comprehensive transition planning, barriers to HCT and then offering a framework for developing and evaluating health care transition programs. Part II focuses on the anatomic and neuro-chemical changes that occur in the brain during adolescence and young adulthood, and how they affect function and behavior. Part III covers the perspectives of important participants in the HCT transition process - youth and young adults, caregivers, and both pediatric and adult providers. Each chapter in Part IV addresses a unique aspect of developing HCT programs. Part V explores various examples of successful transition from the perspective of five key participants in the transition process - patients, caregivers, pediatric providers, adult providers and third party payers. Related financial matters are covered in part VI, while Part VII explores special issues such as HCT and the medical home, international perspectives, and potential legal issues. Models of HCT programs are presented in Part VIII, utilizing an example case study. Representing perspectives from over 75 authors and more than 100 medical centers in North America and Europe, Health Care Transition: Building a Program for Adolescents and Young Adults with Chronic Illness and Disability is an ideal resource for any clinician, policy maker, caregiver, or hospitalist working with youth in transition.

Due to the fact that Restless Legs Syndrome/Willis-Ekbom Disease is usually a chronic condition, this book aims to provide physicians with the necessary tools for the long-term management of patients with RLS. The first part of the book addresses the various comorbidities and long-term consequences of RLS on life quality, sleep, cognitive, psychiatric and cardiovascular systems, while the second part focuses on the management of long-term treatment and the drug-induced complications in primary RLS and in special populations. Written by experts in the field, this practical resource offers a high-quality, long-term management of RLS for neurologists, sleep clinicians, pulmonologists and other healthcare professionals.

The United Nations Madrid International Plan of Action on Ageing (MIPAA) offers a bold new agenda for handling the issue of ageing in the 21st-century. It focuses on three priority areas: older persons and development; advancing health and well-being into old age; and ensuring enabling and supportive environments. This book brings together global perspectives on the MIPAA and focusses on and assesses the success and failures of governments to implement its recommendations. Despite its pivotal importance in international ageing policy, the MIPAA has been relatively neglected by academics in their writings and studies. This book mitigates this analytical and empirical cavity. Each chapter focuses on one specific geographical region and addresses five key themes: National ageing situation; Twenty years of MIPAA; Ensuring ageing with dignity; Healthy and active ageing in a sustainable world; and Priorities for the future. It presents an overall summary of the findings, future challenges and opportunities related to ageing, recommendations for future actions to be taken, and policy adjustments needed. The authors also present lessons that were learnt from managing the impact of COVID-19 on older people, together with an outlook on the most immediate priorities for the future so that the recommendations in the MIPAA are achieved in post-COVID-19 and sustainable ethical scenarios. An important contribution towards the advancement of ageing policy, the book will be indispensable to students and researchers of gerontology, ageing, and health. It will also be of interest to policy makers, geriatricians, dementia care specialists, social policy makers responsible for ensuring active and healthy ageing, and all public sector departments which have specific responsibilities towards improving the quality of life of older adults.

Loving and grieving are two sides of the same coin: we cannot have one without risking the other. Only by understanding the nature and pattern of loving can we begin to understand the problems of grieving. Conversely, the loss of a loved person can teach us much about the nature of love.

Love and Loss, the result of a lifetime's work, has important implications for the study of attachment and bereavement. In this volume, Colin Murray Parkes reports his innovative research that enables us to bring together knowledge of childhood attachments and problems of bereavement, resulting in a new way of thinking about love, bereavement and other losses. Areas covered include:

• patterns of attachment and grief
• loss of a parent, child or spouse in adult life
• social isolation and support.

The book concludes by looking at disorders of attachment and considering bereavement in terms of its implications on love, loss, and change in a wider context.

Illuminating the structure and focus of thinking about love and loss, this book sheds light on a wide range of psychological issues. It will be essential reading for professionals working with bereavement, as well as graduate students of psychology, psychiatry, and sociology.

The SCIP manual will introduce a new assessment tool designed to be compatible with 21st century advances in measurement-base care (MBC) and personalized medicine in psychiatry (PMP). The SCIP includes 18 clinician-administered and 15 self-administered reliable and validated scales covering most adult symptom domains: anxiety, obsessions, compulsions, posttraumatic stress, depression, mania, delusions, hallucinations, disorganized thoughts, aggression, negative symptoms, alcohol use, drug use, attention deficit/hyperactivity, and eating disorders. Mental health professionals (psychiatrists, psychiatry residents, psychologists, therapists, clinical social workers, counselors, nurses, nurse practitioners, physician assistants, professors, students, and mental health researchers) are the primary audience of the manual. These professionals will be able to implement SCIP scales in their practice and use the SCIP psychopathology glossary as part of the emerging science of personalized medicine psychiatry (PMP). Existing books on measures and rating scales, such as the two books above, describe different scales developed by different authors at different periods. Each scale has its own rating guidelines and training requirements, which must be followed by clinicians in order to use the scales. This demands a considerable amount of time for clinicians and can be a barrier to using the scales in practice. Even within the same psychopathology domain, many published measurement scales exist. For instance, the book published by Waters and Stephane includes 120 scales for psychosis. Among the 120 scales for psychosis, which scale(s) should the clinician choose? Our proposed manual will remove these barriers by creating simple and universal principles which allow readers to use the 33 reliable and validated SCIP scales with most adult psychiatric disorders. There will be 15 videotaped interviews available online for readers who buy the book. Readers are expected to watch the interviews in conjunction with reading the manual.

This book provides a comprehensive review of melancholia as a severe disorder of mood, associated with suicide, psychosis, and catatonia. The syndrome is defined with a clear diagnosis, prognosis, and range of management strategies, differentiated from other similar psychiatric, neurological, and general medical conditions. It challenges accepted doctrines in the classification and biology of the mood disorders and defines melancholia as a treatable mental illness. Described for millennia in medical texts and used as a term in literature and poetry, melancholia was included within early versions of the major diagnostic classificatory systems, but lost favour in later editions. This book updates the arguments for the diagnosis, describes its characteristics in detail, and promotes treatment and prevention. The book offers great hope to those with a disorder too often mis-diagnosed and often fatal. It should be read by all those responsible for the management of patients with mood disorders.

Harry S. Guntrip is best known for his affiliation with two other psychoanalysts in the British Independent tradition of psychoanalysis: Ronald Fairbairn and Donald Winnicott. Trevor Dobbs traces the influences on the development of Guntrip's clinical and theological thinking in the context of the tension between religion and psychoanalysis. The central feature was a series of polarities - theoretical and personal - conflicts with which he wrestled theologically, psychologically, and interpersonally both professionally and in his own personality. A critical evaluation of the outcome of Guntrip's own psychoanalyses with Fairbairn and Winnicott shows the autobiographical nature of his theoretical analysis of schizoid phenomena: a psychological state of self-preoccupation and way of being in the world. TREVOR M. DOBBS, PhD, is Core Faculty in the Marriage and Family Therapy Department at Pacific Oaks College in Pasadena, California, and a Supervising and Training Psychoanalyst at the Newport Psychoanalytic Institute, Tustin and Pasadena, California. "Barth wrote that theological existence is the personal existence of the 'little theologian' which is to participate totally in the problematic aspects of the self in community with others. In his exquisite excursion into the influences on Guntrip's life and practice, Trevor Dobbs probes the self's regressive dependence upon the other as an implicit theological existence for which God is the only reality sufficient to sustain the self in its paradoxical quest for relation and autonomy. Reading this reminded me that to be an authentic conversation that includes God, self and others, theology is autobiographical. This is a book that will stimulate and extend that conversation." - Ray S. Anderson, Fuller Theological Seminary "In the century-long dialogue between psychoanalysis and religion, analysts have largely ignored the degree to which religious orientations and concepts might play a role in the development of psychoanalytic thinking and theorizing. Dobbs' careful study brings this perspective into dramatic focus. The pivotal figure is Harry Guntrip - a complex figure, both Congregational minister and psychoanalyst. Dobbs shows the impact of Guntrip's upbringing and beliefs on his psychoanalytic theories. More interesting was his involvement with two psychoanalyic giants - Ronald Fairbairn and Donald Winnicott. Dobbs' detailed analysis reveals how the interactions among the members of this psychoanalytic troika were powerfully shaped and guided by their religious backgrounds and religious commitments. We learn about the reverberations of Guntrip's Wesleyan Congregationalism, Fairbairn's Calvinistic Presbyterianism, and Winnicott's revivalist Methodism on their respective approaches to psychoanalysis and how Guntrip was influenced by Fairburn and Winnicott. The implications speak to the issues of how religion and religious persuasions play a role in how we as analysts think about analysis. This realization opens a broad new territory for exploration and analytic understanding for those interested in the dialogue between psychoanalysis and religion, a dialogue that really is a two-way conversation. Dobbs' reconstruction is an important and valuable contribution - one that enriches our understanding of psychoanalysis itself and that interested readers would be well-advised to ponder." - W.W. Meissner, SJ, MD, Boston College

Schizophrenia was 20th century psychiatry's arch concept of madness. Yet for most of that century it was both problematic and contentious. This history explores schizophrenia's historic instability via themes such as symptoms, definition, classification and anti-psychiatry. In doing so, it opens up new ways of understanding 20th century madness.

Based on a newly developed, practical and relatable ‘Pressure Cooker Model’ which bridges the gap between theoretical models of FND with non-FND specific CBT models. Psychology-led and firmly rooted in psychological principles: written and created by a psychologist who is passionate about psychology treatment for FND. Places a larger emphasis on the active formulation and treatment of social and environmental processes in FND to actively increase awareness of FND and help improve recovery and reduce stigma. Model has wide-spread applicability for different populations with FND, different professionals involved in FND and different therapy formats. Accompanied by an appendix of resources and templates for clinicians

This book presents the similarities and intersections between Autism Spectrum Disorders and comorbid conditions in children. It describes the prevalence and magnitude of comorbid conditions occurring in conjunction with ASD that complicate diagnosis and can potentially lead to inappropriate treatment and negative outcomes. It addresses the strengths and limitations of age-appropriate assessment measures as well as activity and motor skill measurement methods. Specific comorbid disorders are examined through the review of core symptoms, prognostic and diagnostic issues and treatment options for children on the ASD spectrum. Featured topics include: Challenging behaviors in children with ASD. Conditions ranging from feeding and gastrointestinal disorders to epilepsy. Developmental coordination disorder (DCD). Intellectual disability (ID). Methods and procedures for measuring comorbid psychological, medical and motor disorders. Comorbid Conditions Among Children with Autism Spectrum Disorders is a must-have resource for researchers, clinicians and professionals and graduate students across such fields as clinical child, school and developmental psychology, child and adolescent psychiatry and social work as well as rehabilitation medicine/therapy, behavioral therapy, pediatrics and educational psychology.

Clients enter therapy grappling with a range of difficulties. They don't speak in diagnostic terms, but instead focus on the everyday problems that confront them. Their struggles may include isolation, loneliness, anxiety, guilt and regret, and problems making decisions in a world that offers seemingly endless choice. In contrast, the cognitive-behavior therapist is trained in the language of conditioning and extinction, avoidance and safety behaviors, behavioral activation and attentional biases. This book explores the ideas of the existentialist philosophers as a bridge between the suffering client and technically trained clinician. The volume is not a rejection of cognitive behavior therapy (CBT), but seeks to place CBT in the broader context of the most popular philosophic tradition of the 19th and 20th centuries. Therapists versed in existentialism argue that the individual's starting point is characterized by a sense of disorientation in the face of an apparently meaningless and absurd world. Each individual must become solely responsible for giving meaning to life and living it passionately and authentically. Each of us must confront the 'Big 5' existential issues of death, isolation, identity, freedom and meaning and find our solutions to these problems. The present volume explores each of these existential themes in turn. Each section opens with a theoretical chapter describing the relevant existential dilemma and its impact on human experience. The second chapter in each section explores its relationship to mental health disorders and psychopathology. The third chapter in each section explores the evidence for treating the existential issue from a CBT framework. This book will be of value to those interested in CBT, philosophy and mental health, and will appeal to psychotherapists, clinical psychologists and psychiatrists.

Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.

This fully updated third edition of Psychiatry in Medical Practice takes into account major changes in medical education since 1994. New sections provide information on problem-based learning and observed structured clinical examinations. Divided into four sections, this book covers: clinical approaches to the patient syndromes of disorder disorders related to stages of the life cycle services, ethics and the law. As well as retaining the key features of the previous editions, this book includes two brand new chapters on risk assessment and the Mental Health Service. A handy portable reference card is also included; this has been updated to incorporate a scale for assessing cerebral impairment in the elderly, and a new assessment of suicidal risk scale. This highly practical book is an essential guide for all medical students and doctors in training who are involved with psychiatry. It is also a useful reference tool for those who are more experienced in the field.

The development of more effective treatments for neuropsychiatric disorders requires scientific progress on a broad front. Animal models have a vital role to play in advancing the field. When deployed in conjunction with detailed study of these diseases in man they bring the power to make controlled experimental interventions which allow the functional consequences of genetic variations and polymorphisms to be understood in terms of their cellular, systems and behavioural effects. Further, they provide a means by which complex cognitive and behavioural phenomena may be dissected and understood. Finally, they provide a bridge to understanding the effects of drugs on the functioning of the central nervous system, thereby improving our understanding of the actions of those drugs in man.

The number of individuals diagnosed with posttraumatic stress disorder has increased in the past decade, not only in the military and veteran population but within the civilian population as well. Traditional treatments such as pharmacotherapy and psychotherapy have provided less-than-ideal results proving to be less effective when used alone to treat the disorder. Complementary and Alternative Medicine for PTSD supplements these traditional treatments, using new and effective techniques to fill the therapeutic void. The alternative therapies covered include acceptance and commitment therapy, acupuncture, alternative pharmacology, canine assistive therapy, family focused interventions, internet and computer-based therapy, meditation techniques, mobile applications, recreational therapy, resilience training, transracial magnetic stimulation, virtual reality exposure therapy, and yoga. Each chapter delivers the most up-to-date understanding of neurobiology, best practices, and key points for clinicians and patients considering inclusion of these treatments in patient care. COL David Benedek and LTC Gary Wynn offer insight into the future of complementary and alternative medicine, shining a light onto how these techniques fit into clinical practice to create the most beneficial treatments for the patient. This book is both an essential resource and practical guide to everyday clinical interactions. It is a necessary addition to the medical library for students and senior clinicians alike.

This book puts the critical into dementia studies. It makes a timely and novel contribution to the field, offering a provocative and thought-provoking critique of current thinking and debate on dementia. Collectively the contributions gathered together in this text make a powerful case for a more politically engaged, deconstructive and critical treatment of dementia and the systems and structures that currently govern and frame it. The book is interdisciplinary and draws together leading dementia scholars alongside dementia activists from around the world. It frames dementia as first and foremost a political category. The book advances both theoretical and methodological thinking in the field as well as sharing learning from empirical research. Outlining the limits to existing efforts to frame and theorise the condition it proposes a new critical movement for the field of dementia studies and practice. The book will be of direct interest to researchers and scholars in the field of dementia studies and wider fields of health, disability and care. It will provide a novel resource for students and practitioners in the fields of dementia, health care and social care. The book also has implications for dementia policymaking, commissioning and community development.

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.

This edited volume is an anthology of institutional ethnography (IE) inquiries into psychiatry-the first ever to be written. It focuses on a large variety of different geographic locations and constitutes a major contribution to anti/critical psychiatry, as well as institutional ethnography. Themes include the DSM, the use and protection of problematic psychiatric research, the penetration of psychiatry into the workplace. Adding depth and breath, the contributors, while all are schooled in IE, come from a large variety of walks of life, authors including: academics, psychiatric survivors, investigative reporters, activists, nurses, artists, and lawyers-each bringing their own unique expertise/standpoint to bear. The result is an intellectually rigorous book, contributions to several disciplines, ammunition for activism, and a compelling read that cannot be put down.

This foundational work comprehensively examines the current state of the genetics, genomics and brain circuitry of psychiatric and neurological disorders. It consolidates discoveries of specific genes and genomic regions associated with these conditions, the genetic and anatomic architecture of these syndromes, and addresses how recent advances in genomics are leading to a reappraisal of the biology underlying clinical neuroscience. In doing so, it critically examines the promise and limitations of these discoveries toward treatment, and to the interdisciplinary nature of understanding brain and behavior. Coverage includes new discoveries regarding autism, epilepsy, intellectual disability, dementias, movement disorders, language impairment, disorders of attention, schizophrenia, and bipolar disorder. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry focuses on key concepts, challenges, findings, and methods in genetics, genomics, molecular pathways, brain circuitry, and related neurobiology of neurologic and psychiatric disorders.

The field of academic psychiatry is in crisis, everywhere. It is not merely a health crisis of resource scarcity or distribution, competing claims and practice models, or level of development from one country to another, but a deeper, more fundamental crisis about the very definition and the theoretical basis of psychiatry. The kinds of questions that represent this crisis include whether psychiatry is a social science (like psychology or anthropology), whether it is better understood as part of the humanities (like philosophy, history, and literature), or if the future of psychiatry is best assured as a branch of medicine (based on genetics and neuroscience)? In fact, the question often debated since the beginning of modern psychiatry concerns the biomedical model so that part of psychiatry's perpetual self-questioning is to what extent it is or is not a branch of medicine. This unique and bold volume offers a representative and critical survey of the history of modern psychiatry with deeply informed transdisciplinary readings of the literature and practices of the field by two professors of psychiatry who are active in practice and engaged in research and have dual training in scientific psychiatry and philosophy. In alternating chapters presenting contrasting arguments for the future of psychiatry, the two authors conclude with a dialogue between them to flesh out the theoretical, research, and practical implications of psychiatry's current crisis, outlining areas of divergence, consensus, and fruitful collaborations to revision psychiatry today. The volume is scrupulously documented but written in accessible language with capsule summaries of key areas of theory, research, and practice for the student and practitioner alike in the social and human sciences and in medicine, psychiatry, and the neurosciences.

Based on extensive research, this book is a fundamental critique of psychiatry that examines the foundations of psychiatry, refutes its basic tenets, and traces the workings of the industry through medical research and in-depth interviews.